China Health Group Inc.
HHKEX:82250.07
HKD
+0.00
(-1.43%)
ISIN
KYG2117N1088
CUSIP
G2117N108
Return %
Stock
S&P 500
1Y
-58.68
14.20
3Y
-59.41
81.12
5Y
-85.00
68.34
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Semi-annual Revenue
CNY
•
in mil. unless spec.Semi-annual Earnings Per Share
CNY
•
in mil. unless spec.Semi-annual Dividends Per Share
CNY
•
in mil. unless spec.Company Description
- CEO
- Zhuang Xiangsong
- Full Time Employees
- 32
- Sector
- Health technology
- Industry
- Pharmaceuticals: other
- Address
- Building 17 Beijing BE China 102200
- IPO Date
- Jul 10, 2003
- Website
- chgi.net
- Similar Companies
- Business
- China Health Group Inc. (Ticker: 8225.HK) is a health-focused company primarily engaged in the manufacturing, distribution, and retail of medical and healthcare products and services. The company's core offerings include pharmaceutical manufacturing; provision and sale of healthcare and wellness products; operation of medical and health management services; pharmaceutical retail; and distribution of medical equipment and supplies. Its product portfolio encompasses traditional Chinese medicine, Western medicines, nutritional supplements, medical devices, and health-related consumer goods. The company operates predominantly in China, targeting healthcare institutions, pharmacies, and end consumers with an emphasis on integrating traditional and modern medical practices. Founded in 2007 and headquartered in Hong Kong, China Health Group Inc. has recently engaged in strategic initiatives to expand its market presence and service offerings. In the past 1-2 years, the company has pursued strategic partnerships aimed at enhancing its pharmaceutical distribution network and expanding digital health management services. It has also launched new product lines incorporating advanced medical technologies and integrated health solutions to address emerging market demands for personalized healthcare. These initiatives align with its broader strategic shift towards becoming a comprehensive healthcare provider, combining product manufacturing, distribution, retail, and health management services under one umbrella. The company continues to leverage its position in China's growing healthcare sector by strengthening operational capabilities and expanding its footprint across key regional markets. China Health Group operates in the healthcare and pharmaceutical industry segment with a business model that incorporates manufacturing, distribution, retail, and healthcare service delivery. Its target markets include hospitals, clinics, pharmacies, health-conscious consumers, and wellness centers across mainland China and Hong Kong. The company has several subsidiaries focusing on different aspects of healthcare delivery and product development, enabling it to provide a wide range of medical and health-related products and services within the Greater China region. Overall, China Health Group Inc. positions itself as a diversified healthcare conglomerate focused on delivering integrated medical and healthcare solutions through product innovation, strategic partnerships, and comprehensive service offerings in China’s evolving healthcare market.